Demo Sign up Log In

R&D Expenses

$495.60M

Quarterly · Period ending: Jun 30, 2026 · USD

BIIB R&D Expenses

Latest reported$495.60Mperiod endingJun 30, 2026

Latest reported$495.60Mperiod endingJun 30, 2026

BIIB Quarterly R&D Expenses ($0.00 → $495.60M)

Quarterly R&D Expenses

High-resolution chart · PNG

BIIB r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	79,118,000
Mar 31, 2001	72,770,000
Dec 31, 2000	73,635,000
Sep 30, 2000	94,498,000
Jun 30, 2000	71,701,000
Mar 31, 2000	63,006,000
Dec 31, 1999	60,253,000
Sep 30, 1999	59,000,000
Jun 30, 1999	50,900,000
Mar 31, 1999	51,000,000
Dec 31, 1998	48,928,000
Sep 30, 1998	49,100,000
Jun 30, 1998	42,100,000
Mar 31, 1998	37,100,000
Dec 31, 1997	38,501,000
Sep 30, 1997	37,000,000
Jun 30, 1997	32,000,000
Mar 31, 1997	37,900,000
Dec 31, 1996	48,184,000
Sep 30, 1996	30,400,000
Jun 30, 1996	29,300,000
Mar 31, 1996	24,500,000
Dec 31, 1995	23,248,000
Sep 30, 1995	22,500,000
Jun 30, 1995	21,300,000
Mar 31, 1995	20,400,000
Dec 31, 1994	18,813,000
Sep 30, 1994	22,800,000
Jun 30, 1994	26,300,000
Mar 31, 1994	23,300,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.